Cardlytics Total Liab from 2010 to 2025

CDLX Stock  USD 3.06  0.10  3.16%   
Cardlytics Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities will likely drop to about 342 M in 2025. Total Liabilities is the total amount of all liabilities that Cardlytics has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2015-12-31
Previous Quarter
324.3 M
Current Value
329.7 M
Quarterly Volatility
178.6 M
 
Yuan Drop
 
Covid
Check Cardlytics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardlytics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Interest Income of 3.4 M or Depreciation And Amortization of 35.6 M, as well as many indicators such as Price To Sales Ratio of 0.93, Dividend Yield of 0.0 or PTB Ratio of 3.76. Cardlytics financial statements analysis is a perfect complement when working with Cardlytics Valuation or Volatility modules.
  
Check out the analysis of Cardlytics Correlation against competitors.
For more information on how to buy Cardlytics Stock please use our How to Invest in Cardlytics guide.

Latest Cardlytics' Total Liab Growth Pattern

Below is the plot of the Total Liab of Cardlytics over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Cardlytics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardlytics' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Cardlytics Total Liab Regression Statistics

Arithmetic Mean304,206,460
Geometric Mean272,341,774
Coefficient Of Variation44.66
Mean Deviation102,935,700
Median265,345,000
Standard Deviation135,871,872
Sample Variance18461.2T
Range492.1M
R-Value0.55
Mean Square Error13830.8T
R-Squared0.30
Significance0.03
Slope15,651,219
Total Sum of Squares276917.5T

Cardlytics Total Liab History

2025342 M
2024505.2 M
2023439.3 M
2022479.6 M
2021573.1 M
2020265.3 M
201981 M

About Cardlytics Financial Statements

Cardlytics investors use historical fundamental indicators, such as Cardlytics' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardlytics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities505.2 M342 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardlytics Stock Analysis

When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.